Topical Reconstituted High-Density Lipoproteins Elicit Anti-Inflammatory Effects in Diabetic Wounds
Zahra Lotfollahi(South Australian Health and Medical Research Institute), Christina A. Bursill(Australian Research Council), Lauren Sandeman(South Australian Health and Medical Research Institute), Victoria Nankivell(South Australian Health and Medical Research Institute), Joseph Dawson(Royal Adelaide Hospital), Stephen J. Nicholls(Australian Centre for Heart Health), Peter J. Psaltis(South Australian Health and Medical Research Institute), Robert Fitridge(Royal Adelaide Hospital), Anna E. Williamson(Pfizer (United States)), Liam Stretton(Royal Adelaide Hospital), Emma L. Solly(South Australian Health and Medical Research Institute), S. Liyanage(Inje University)
Cited by 4
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k